Kyverna Therapeutics Analyst Ratings
Barclays Starts Waystar Holding With Overweight Rating, $24 Price Target
Waystar Holding Corp. (WAY) Receives a New Rating From Barclays
BofA, J.P. Morgan Start Coverage of Waystar With Bullish Ratings
Core Scientific Analyst Ratings
Viking Holdings Analyst Ratings
Buy Rating Affirmed: Waystar Holding Corp's Dominance in Healthcare Payments and Revenue Cycle Management
Canaccord Genuity Initiates Waystar Holding at Buy With $30 Price Target
Rapport Therapeutics Analyst Ratings
GE Vernova Analyst Ratings
Life360 Analyst Ratings
Redburn Atlantic Initiates GE Vernova at Neutral With $178 Price Target
Analysts Are Bullish on These NA Stocks: Waystar Holding Corp. (WAY), Life360, Inc. (LIF)
Waystar Holding Analyst Ratings
Buy Rating for Rapport Therapeutics: Disruptive CNS Treatments and Promising Drug Efficacy
Buy Rating Initiated for Waystar Holding Corp. on Strong Market Position and Healthy Financials
American Healthcares Analyst Ratings
Gauzy Analyst Ratings
Gauzy Ltd. (GAUZ) Initiated With a Buy at TD Cowen
Buy Rating Affirmed for Gauzy Ltd. on Strong Growth and Positive Financial Outlook